These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9756031)

  • 1. Modulation of volitional ethanol intake in the rat by central delta-opioid receptors.
    Franck J; Lindholm S; Raaschou P
    Alcohol Clin Exp Res; 1998 Sep; 22(6):1185-9. PubMed ID: 9756031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypericum perforatum CO2 extract and opioid receptor antagonists act synergistically to reduce ethanol intake in alcohol-preferring rats.
    Perfumi M; Santoni M; Cippitelli A; Ciccocioppo R; Froldi R; Massi M
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1554-62. PubMed ID: 14574225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective delta-opioid receptor antagonist N,N(CH3)2-Dmt-Tic-OH does not reduce ethanol intake in alcohol-preferring AA rats.
    Ingman K; Salvadori S; Lazarus L; Korpi ER; Honkanen A
    Addict Biol; 2003 Jun; 8(2):173-9. PubMed ID: 12850776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid activation in the lateral parabrachial nucleus induces hypertonic sodium intake.
    De Oliveira LB; De Luca LA; Menani JV
    Neuroscience; 2008 Aug; 155(2):350-8. PubMed ID: 18602454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in mu-opioid receptor density.
    Cowen MS; Rezvani AH; Jarrott B; Lawrence AJ
    Alcohol Clin Exp Res; 1999 Jun; 23(6):1008-14. PubMed ID: 10397284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High voluntary alcohol consumption, in experimental liver cirrhosis is hardly responsive to opioid antagonist treatment.
    Stasiak A; Fogel WA
    J Physiol Pharmacol; 2008 Mar; 59(1):101-14. PubMed ID: 18441391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats.
    Honkanen A; Vilamo L; Wegelius K; Sarviharju M; Hyytiä P; Korpi ER
    Eur J Pharmacol; 1996 May; 304(1-3):7-13. PubMed ID: 8813578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol consumption is enhanced after naltrexone treatment.
    Juárez J; Eliana Bde T
    Alcohol Clin Exp Res; 2007 Feb; 31(2):260-4. PubMed ID: 17250617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and long term effects of buspirone treatments on voluntary ethanol intake in a rat model of alcoholism.
    Hedlund L; Wahlström G
    Alcohol Clin Exp Res; 1999 May; 23(5):822-7. PubMed ID: 10371401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone blocks acquisition of voluntary ethanol intake in rats.
    Davidson D; Amit Z
    Alcohol Clin Exp Res; 1997 Jun; 21(4):677-83. PubMed ID: 9194924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro1-opioid antagonist naloxonazine alters ethanol discrimination and consumption.
    Mhatre M; Holloway F
    Alcohol; 2003 Feb; 29(2):109-16. PubMed ID: 12782252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissection of peripheral and central endogenous opioid modulation of systemic interleukin-1beta responses using c-fos expression in the rat brain.
    Buller KM; Hamlin AS; Osborne PB
    Neuropharmacology; 2005 Aug; 49(2):230-42. PubMed ID: 15993445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution of dopamine autoreceptors in the reactive effect of opioid antagonists].
    Dubrovina NI
    Biull Eksp Biol Med; 1995 Feb; 119(2):120-4. PubMed ID: 7670029
    [No Abstract]   [Full Text] [Related]  

  • 15. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
    Gyires K; Rónai AZ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens.
    Zhang M; Kelley AE
    Psychopharmacology (Berl); 2002 Feb; 159(4):415-23. PubMed ID: 11823894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors.
    Liu JG; Prather PL
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1070-9. PubMed ID: 12183665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone and baclofen attenuate ethanol's locomotor-activating effects in preweanling Sprague-Dawley rats.
    Arias C; Mlewski EC; Molina JC; Spear NE
    Behav Neurosci; 2009 Feb; 123(1):172-80. PubMed ID: 19170442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of alcohol intake by chronic naloxone treatment in P rats: tolerance development and elevation of opiate receptor binding.
    Overstreet DH; Kampov-Polevoy AB; Rezvani AH; Braun C; Bartus RT; Crews FT
    Alcohol Clin Exp Res; 1999 Nov; 23(11):1761-71. PubMed ID: 10591592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atypical anxiolytic N-phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P rats.
    Rezvani AH; Overstreet DH; Levin ED; Rosenthal DI; Kordik CP; Reitz AB; Vaidya AH
    Alcohol Clin Exp Res; 2007 Jan; 31(1):57-63. PubMed ID: 17207102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.